SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
+13.1%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$283M
AUM Growth
+$283M
Cap. Flow
+$3.02M
Cap. Flow %
1.07%
Top 10 Hldgs %
97.4%
Holding
18
New
4
Increased
2
Reduced
1
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$88.3M 31.25% 12,850,000
DGX icon
2
Quest Diagnostics
DGX
$20.3B
$52M 18.4% 775,000
AMGN icon
3
Amgen
AMGN
$155B
$50.7M 17.93% 318,000 +198,000 +165% +$31.5M
MRK icon
4
Merck
MRK
$210B
$22.7M 8.04% 400,000
A icon
5
Agilent Technologies
A
$35.7B
$18.8M 6.67% 460,000
BRLI
6
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$12.5M 4.44% 390,270 -890,714 -70% -$28.6M
RPRX
7
DELISTED
Repros Therapeutics Inc.
RPRX
$11.3M 4% 1,132,367
VVUS
8
DELISTED
Vivus Inc
VVUS
$7.41M 2.62% 2,573,943
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.35M 2.25% 360,000
KIN
10
DELISTED
Kindred Biosciences, Inc.
KIN
$5.13M 1.82% 689,091 +299,091 +77% +$2.23M
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.16M 0.76% 2,570,759
ANIP icon
12
ANI Pharmaceuticals
ANIP
$2.03B
$1.75M 0.62% +31,000 New +$1.75M
GYRE icon
13
Gyre Therapeutics
GYRE
$703M
$1.66M 0.59% 630,000
SEEL
14
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$1.03M 0.36% +1,030,000 New +$1.03M
CARM icon
15
Carisma Therapeutics
CARM
$8.98M
$489K 0.17% +41,200 New +$489K
CYCC icon
16
Cyclacel Pharmaceuticals
CYCC
$18.4M
$263K 0.09% +376,000 New +$263K
ENTA icon
17
Enanta Pharmaceuticals
ENTA
$180M
-105,000 Closed -$4.16M
TRAW icon
18
Traws Pharma
TRAW
$9.89M
-350,000 Closed -$1.51M